Compare commits
20 commits
25d5a32843
...
88adff20c0
| Author | SHA1 | Date | |
|---|---|---|---|
|
|
88adff20c0 | ||
|
|
458aa7494e | ||
| 54869f7e31 | |||
|
|
994f00fe77 | ||
| 8a471a1fae | |||
|
|
cea1db6bc4 | ||
| feaa2acfa8 | |||
| 5ec31622a9 | |||
|
|
3c3e743d36 | ||
|
|
8beedfd204 | ||
| d378ee8721 | |||
|
|
e82a6f0896 | ||
| b7975678e3 | |||
|
|
658fae9a25 | ||
| 200b4f39d4 | |||
|
|
5fcb46aca2 | ||
| b8614ca9eb | |||
|
|
f2c3d656f3 | ||
| ae440ed989 | |||
|
|
0d3a4acd50 |
24 changed files with 345 additions and 26 deletions
|
|
@ -27,6 +27,12 @@ This is not an American problem alone. The American diet and lifestyle are sprea
|
|||
|
||||
The four major risk factors behind the highest burden of noncommunicable disease -- tobacco use, harmful use of alcohol, unhealthy diets, and physical inactivity -- are all lifestyle factors that simple interventions could address. The gap between what science knows works (lifestyle modification) and what the system delivers (pharmaceutical symptom management) represents one of the largest misalignments in the modern economy.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-06-01-cell-med-glp1-societal-implications-obesity]] | Added: 2026-03-15*
|
||||
|
||||
GLP-1s may function as a pharmacological counter to engineered food addiction. The population-level obesity decline (39.9% to 37.0%) coinciding with 12.4% adult GLP-1 adoption suggests pharmaceutical intervention can partially offset the metabolic consequences of engineered hyperpalatable foods, though this addresses symptoms rather than root causes of the food environment.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -23,6 +23,12 @@ The competitive dynamics (Lilly vs. Novo vs. generics post-2031) will drive pric
|
|||
|
||||
Real-world persistence data from 125,474 commercially insured patients shows the chronic use model fails not because patients choose indefinite use, but because most cannot sustain it: only 32.3% of non-diabetic obesity patients remain on GLP-1s at one year, dropping to approximately 15% at two years. This creates a paradox for payer economics—the "inflationary chronic use" concern assumes sustained adherence, but the actual problem is insufficient persistence. Under capitation, payers pay for 12 months of therapy ($2,940 at $245/month) for patients who discontinue and regain weight, capturing net cost with no downstream savings from avoided complications. The economics only work if adherence is sustained AND the payer captures downstream benefits—with 85% discontinuing by two years, the downstream cardiovascular and metabolic savings that justify the cost never materialize for most patients.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-06-01-cell-med-glp1-societal-implications-obesity]] | Added: 2026-03-15*
|
||||
|
||||
The Cell Press review characterizes GLP-1s as marking a 'system-level redefinition' of cardiometabolic management with 'ripple effects across healthcare costs, insurance models, food systems, long-term population health.' Obesity costs the US $400B+ annually, providing context for the scale of potential cost impact. The WHO issued conditional recommendations within 2 years of widespread adoption (December 2025), unusually fast for a major therapeutic category.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -61,7 +61,7 @@ The NHS demonstrates that you cannot have universal gatekeeping, excellent prima
|
|||
### Additional Evidence (confirm)
|
||||
*Source: [[2025-00-00-nhs-england-waiting-times-underfunding]] | Added: 2026-03-15*
|
||||
|
||||
NHS data shows only 58.9% of 7.5M waiting patients seen within 18 weeks (target: 92%) and 22% waiting >6 weeks for diagnostic tests (standard: 1%). The GP referral requirement that strengthens primary care creates specialty bottlenecks, with trauma/orthopaedics and ENT showing largest waiting times. This confirms the structural tradeoff is not a temporary inefficiency but an architectural feature of gatekeeping systems.
|
||||
NHS data shows that while the system ranks 3rd overall in Commonwealth Fund rankings due to strong primary care and GP gatekeeping, only 58.9% of specialty patients are seen within 18 weeks versus a 92% target, with 22% waiting over 6 weeks for diagnostic tests. The GP referral requirement that strengthens primary care creates a structural bottleneck where specialty demand exceeds capacity by a factor requiring the waiting list to be halved just to reach minimum standards.
|
||||
|
||||
---
|
||||
|
||||
|
|
|
|||
|
|
@ -35,6 +35,12 @@ This has structural implications for how healthcare should be organized. Since [
|
|||
|
||||
The Commonwealth Fund's 2024 Mirror Mirror international comparison provides the strongest real-world proof of this claim. The US ranks **second in care process quality** (clinical excellence when care is accessed) but **last in health outcomes** (life expectancy, avoidable deaths) among 10 peer nations. This paradox proves that clinical quality alone cannot produce population health — the US has near-best clinical care AND worst outcomes, demonstrating that non-clinical factors (access, equity, social determinants) dominate outcome determination. The care process vs. outcomes decoupling across 70 measures and nearly 75% patient/physician-reported data is the international benchmark showing medical care's limited contribution to population health outcomes.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-00-00-nhs-england-waiting-times-underfunding]] | Added: 2026-03-15*
|
||||
|
||||
The NHS paradox—ranking 3rd overall while having catastrophic specialty access—provides supporting evidence that medical care's contribution to health outcomes is limited. A system can have multi-year waits for specialty procedures yet still rank highly in overall health system performance because primary care, equity, and universal coverage (which address behavioral and social factors) matter more than specialty delivery speed for population health outcomes.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -31,6 +31,12 @@ Since specialization and value form an autocatalytic feedback loop where each am
|
|||
|
||||
The Commonwealth Fund's 2024 international comparison demonstrates this transition empirically across 10 developed nations. All countries compared (Australia, Canada, France, Germany, Netherlands, New Zealand, Sweden, Switzerland, UK, US) have eliminated material scarcity in healthcare — all possess advanced clinical capabilities and universal or near-universal access infrastructure. Yet health outcomes vary dramatically. The US spends >16% of GDP (highest by far) with worst outcomes, while top performers (Australia, Netherlands) spend the lowest percentage of GDP. The differentiator is not clinical capability (US ranks 2nd in care process quality) but access structures and equity — social determinants. This proves that among developed nations with sufficient material resources, social disadvantage (who gets care, discrimination, equity barriers) drives outcomes more powerfully than clinical quality or spending volume.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-06-01-cell-med-glp1-societal-implications-obesity]] | Added: 2026-03-15*
|
||||
|
||||
GLP-1 access inequality demonstrates the epidemiological transition in action: the intervention addresses metabolic disease (post-transition health problem) but access stratifies by wealth and insurance status (social disadvantage), potentially widening health inequalities even as population-level outcomes improve. The WHO's emphasis on 'multisectoral action' and 'healthier environments' acknowledges that pharmaceutical solutions alone cannot address socially-determined health outcomes.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -40,7 +40,7 @@ This is the definitive international benchmark showing that the US healthcare sy
|
|||
### Additional Evidence (extend)
|
||||
*Source: [[2025-00-00-nhs-england-waiting-times-underfunding]] | Added: 2026-03-15*
|
||||
|
||||
The NHS ranks 3rd in Commonwealth Fund Mirror Mirror 2024 despite having the worst specialty access among peer nations, demonstrating that the methodology weights access, equity, and primary care more heavily than specialty outcomes. This reveals that international comparisons can produce opposite conclusions depending on which dimensions are prioritized—the US ranks last overall but would rank higher on specialty access speed, while the NHS ranks 3rd overall but last on specialty access.
|
||||
The NHS provides the inverse comparison: ranking 3rd overall in Commonwealth Fund Mirror Mirror 2024 despite having the worst specialty access and longest waiting times among peer nations. This reveals that the Commonwealth Fund methodology weights universal coverage, primary care access, and equity more heavily than specialty delivery outcomes. The US ranks last due to access/equity failures; the NHS ranks high despite specialty failures. Both demonstrate that no system optimizes all dimensions simultaneously—tradeoffs are structural.
|
||||
|
||||
---
|
||||
|
||||
|
|
|
|||
|
|
@ -77,6 +77,12 @@ Autocrat v0.1 made the three-day window configurable rather than hardcoded, with
|
|||
|
||||
Proposal #3 on MetaDAO (account EXehk1u3qUJZSxJ4X3nHsiTocRhzwq3eQAa6WKxeJ8Xs) ran on Autocrat version 0.3, created 2024-07-04, and completed/ended 2024-07-08 - confirming the four-day operational window (proposal creation plus three-day settlement period) specified in the mechanism design.
|
||||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2025-03-05-futardio-proposal-proposal-1]] | Added: 2026-03-15*
|
||||
|
||||
Production deployment data from futard.io shows Proposal #1 on DAO account De8YzDKudqgeJXqq6i7q82AgxxrQ1JXXfMgouQuPyhY using Autocrat version 0.3, with proposal created, ended, and completed all on 2025-03-05. This confirms operational use of the Autocrat v0.3 implementation in live governance.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -49,6 +49,7 @@ MetaDAO's token launch platform. Implements "unruggable ICOs" — permissionless
|
|||
- **2026-03-05** — [[insert-coin-labs-futardio-fundraise]] launched for Web3 gaming studio (failed, $2,508 / $50K = 5% of target)
|
||||
- **2026-03-05** — [[git3-futardio-fundraise]] failed: Git3 raised $28,266 of $100K target (28.3%) before entering refunding status, demonstrating market filtering even with live MVP
|
||||
- **2024-06-14** — [[futardio-fund-rug-bounty-program]] passed: Approved $5K USDC funding for RugBounty.xyz platform development to incentivize community recovery from rug pulls
|
||||
- **2024-08-28** — MetaDAO proposal to develop futardio as memecoin launchpad with futarchy governance failed. Proposal would have allocated $100k grant over 6 months to development team. Key features: percentage of each new token supply allocated to futarchy DAO, points-to-token conversion within 180 days, revenue distribution to $FUTA holders, immutable deployment on IPFS/Arweave. Proposal rejected by market, suggesting reputational risks outweighed adoption benefits.
|
||||
## Competitive Position
|
||||
- **Unique mechanism**: Only launch platform with futarchy-governed accountability and treasury return guarantees
|
||||
- **vs pump.fun**: pump.fun is memecoin launch (zero accountability, pure speculation). Futardio is ownership coin launch (futarchy governance, treasury enforcement). Different categories despite both being "launch platforms."
|
||||
|
|
|
|||
|
|
@ -0,0 +1,44 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "futarchy-information-advantage-scales-with-information-asymmetry-converging-to-voting-in-aligned-expert-communities.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "kpi-conditional-futarchy-is-more-appropriate-than-asset-price-futarchy-for-thinly-traded-organizations-coupled-to-external-market-sentiment.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "governance-cadence-below-one-proposal-per-month-is-incompatible-with-continuous-futarchy-because-infrequent-decisions-reduce-market-learning-and-liquidity-accumulation.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 3,
|
||||
"kept": 0,
|
||||
"fixed": 7,
|
||||
"rejected": 3,
|
||||
"fixes_applied": [
|
||||
"futarchy-information-advantage-scales-with-information-asymmetry-converging-to-voting-in-aligned-expert-communities.md:set_created:2026-03-15",
|
||||
"futarchy-information-advantage-scales-with-information-asymmetry-converging-to-voting-in-aligned-expert-communities.md:stripped_wiki_link:speculative-markets-aggregate-information-through-incentive-",
|
||||
"futarchy-information-advantage-scales-with-information-asymmetry-converging-to-voting-in-aligned-expert-communities.md:stripped_wiki_link:MetaDAOs-futarchy-implementation-shows-limited-trading-volum",
|
||||
"kpi-conditional-futarchy-is-more-appropriate-than-asset-price-futarchy-for-thinly-traded-organizations-coupled-to-external-market-sentiment.md:set_created:2026-03-15",
|
||||
"kpi-conditional-futarchy-is-more-appropriate-than-asset-price-futarchy-for-thinly-traded-organizations-coupled-to-external-market-sentiment.md:stripped_wiki_link:coin-price-is-the-fairest-objective-function-for-asset-futar",
|
||||
"governance-cadence-below-one-proposal-per-month-is-incompatible-with-continuous-futarchy-because-infrequent-decisions-reduce-market-learning-and-liquidity-accumulation.md:set_created:2026-03-15",
|
||||
"governance-cadence-below-one-proposal-per-month-is-incompatible-with-continuous-futarchy-because-infrequent-decisions-reduce-market-learning-and-liquidity-accumulation.md:stripped_wiki_link:MetaDAOs-futarchy-implementation-shows-limited-trading-volum"
|
||||
],
|
||||
"rejections": [
|
||||
"futarchy-information-advantage-scales-with-information-asymmetry-converging-to-voting-in-aligned-expert-communities.md:missing_attribution_extractor",
|
||||
"kpi-conditional-futarchy-is-more-appropriate-than-asset-price-futarchy-for-thinly-traded-organizations-coupled-to-external-market-sentiment.md:missing_attribution_extractor",
|
||||
"governance-cadence-below-one-proposal-per-month-is-incompatible-with-continuous-futarchy-because-infrequent-decisions-reduce-market-learning-and-liquidity-accumulation.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-15"
|
||||
}
|
||||
|
|
@ -7,7 +7,7 @@
|
|||
]
|
||||
},
|
||||
{
|
||||
"filename": "chronic-underfunding-produces-exponential-not-linear-degradation-in-healthcare-access.md",
|
||||
"filename": "chronic-underfunding-produces-exponential-degradation-in-specialty-access-as-nhs-respiratory-wait-times-show-263-percent-growth.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
|
|
@ -16,16 +16,15 @@
|
|||
"validation_stats": {
|
||||
"total": 2,
|
||||
"kept": 0,
|
||||
"fixed": 3,
|
||||
"fixed": 2,
|
||||
"rejected": 2,
|
||||
"fixes_applied": [
|
||||
"nhs-demonstrates-universal-coverage-without-adequate-funding-produces-excellent-primary-care-but-catastrophic-specialty-access.md:set_created:2026-03-15",
|
||||
"nhs-demonstrates-universal-coverage-without-adequate-funding-produces-excellent-primary-care-but-catastrophic-specialty-access.md:stripped_wiki_link:medical care explains only 10 20 percent of health outcomes ",
|
||||
"chronic-underfunding-produces-exponential-not-linear-degradation-in-healthcare-access.md:set_created:2026-03-15"
|
||||
"chronic-underfunding-produces-exponential-degradation-in-specialty-access-as-nhs-respiratory-wait-times-show-263-percent-growth.md:set_created:2026-03-15"
|
||||
],
|
||||
"rejections": [
|
||||
"nhs-demonstrates-universal-coverage-without-adequate-funding-produces-excellent-primary-care-but-catastrophic-specialty-access.md:missing_attribution_extractor",
|
||||
"chronic-underfunding-produces-exponential-not-linear-degradation-in-healthcare-access.md:missing_attribution_extractor"
|
||||
"chronic-underfunding-produces-exponential-degradation-in-specialty-access-as-nhs-respiratory-wait-times-show-263-percent-growth.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
|
|
|
|||
|
|
@ -0,0 +1,46 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "alignment-impossibility-converges-across-three-mathematical-traditions.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "reward-hacking-is-globally-inevitable-in-finite-sample-regimes.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "consensus-driven-objective-reduction-is-the-practical-pathway-out-of-alignment-impossibility.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 3,
|
||||
"kept": 0,
|
||||
"fixed": 9,
|
||||
"rejected": 3,
|
||||
"fixes_applied": [
|
||||
"alignment-impossibility-converges-across-three-mathematical-traditions.md:set_created:2026-03-15",
|
||||
"alignment-impossibility-converges-across-three-mathematical-traditions.md:stripped_wiki_link:universal-alignment-is-mathematically-impossible-because-arr",
|
||||
"alignment-impossibility-converges-across-three-mathematical-traditions.md:stripped_wiki_link:single-reward-rlhf-cannot-align-diverse-preferences-because-",
|
||||
"reward-hacking-is-globally-inevitable-in-finite-sample-regimes.md:set_created:2026-03-15",
|
||||
"reward-hacking-is-globally-inevitable-in-finite-sample-regimes.md:stripped_wiki_link:emergent-misalignment-arises-naturally-from-reward-hacking-a",
|
||||
"reward-hacking-is-globally-inevitable-in-finite-sample-regimes.md:stripped_wiki_link:the-specification-trap-means-any-values-encoded-at-training-",
|
||||
"consensus-driven-objective-reduction-is-the-practical-pathway-out-of-alignment-impossibility.md:set_created:2026-03-15",
|
||||
"consensus-driven-objective-reduction-is-the-practical-pathway-out-of-alignment-impossibility.md:stripped_wiki_link:universal-alignment-is-mathematically-impossible-because-arr",
|
||||
"consensus-driven-objective-reduction-is-the-practical-pathway-out-of-alignment-impossibility.md:stripped_wiki_link:community-centred-norm-elicitation-surfaces-alignment-target"
|
||||
],
|
||||
"rejections": [
|
||||
"alignment-impossibility-converges-across-three-mathematical-traditions.md:missing_attribution_extractor",
|
||||
"reward-hacking-is-globally-inevitable-in-finite-sample-regimes.md:missing_attribution_extractor",
|
||||
"consensus-driven-objective-reduction-is-the-practical-pathway-out-of-alignment-impossibility.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-15"
|
||||
}
|
||||
|
|
@ -0,0 +1,24 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "marinade-sam-bid-routing-to-mnde-stakers-creates-performance-fee-alignment-between-validator-selection-and-governance-token-holders.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 1,
|
||||
"kept": 0,
|
||||
"fixed": 1,
|
||||
"rejected": 1,
|
||||
"fixes_applied": [
|
||||
"marinade-sam-bid-routing-to-mnde-stakers-creates-performance-fee-alignment-between-validator-selection-and-governance-token-holders.md:set_created:2026-03-15"
|
||||
],
|
||||
"rejections": [
|
||||
"marinade-sam-bid-routing-to-mnde-stakers-creates-performance-fee-alignment-between-validator-selection-and-governance-token-holders.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-15"
|
||||
}
|
||||
|
|
@ -0,0 +1,35 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "working-group-model-creates-self-sustaining-community-engagement-through-independent-operation-with-initial-core-team-collaboration.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "futarchy-governed-community-working-groups-use-trial-periods-with-performance-metrics-to-validate-experimental-initiatives.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 2,
|
||||
"kept": 0,
|
||||
"fixed": 5,
|
||||
"rejected": 2,
|
||||
"fixes_applied": [
|
||||
"working-group-model-creates-self-sustaining-community-engagement-through-independent-operation-with-initial-core-team-collaboration.md:set_created:2026-03-15",
|
||||
"working-group-model-creates-self-sustaining-community-engagement-through-independent-operation-with-initial-core-team-collaboration.md:stripped_wiki_link:dao-event-perks-as-governance-incentives-create-plutocratic-",
|
||||
"futarchy-governed-community-working-groups-use-trial-periods-with-performance-metrics-to-validate-experimental-initiatives.md:set_created:2026-03-15",
|
||||
"futarchy-governed-community-working-groups-use-trial-periods-with-performance-metrics-to-validate-experimental-initiatives.md:stripped_wiki_link:futarchy-proposals-with-favorable-economics-can-fail-due-to-",
|
||||
"futarchy-governed-community-working-groups-use-trial-periods-with-performance-metrics-to-validate-experimental-initiatives.md:stripped_wiki_link:metadao-autocrat-v01-reduces-proposal-duration-to-three-days"
|
||||
],
|
||||
"rejections": [
|
||||
"working-group-model-creates-self-sustaining-community-engagement-through-independent-operation-with-initial-core-team-collaboration.md:missing_attribution_extractor",
|
||||
"futarchy-governed-community-working-groups-use-trial-periods-with-performance-metrics-to-validate-experimental-initiatives.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-15"
|
||||
}
|
||||
|
|
@ -0,0 +1,32 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "glp-1-adoption-produced-first-measurable-population-level-obesity-decline-demonstrating-pharmaceutical-intervention-can-shift-population-health-outcomes.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "glp-1-access-inequality-risks-creating-two-tier-metabolic-health-system-where-pharmacological-prevention-stratifies-by-wealth-while-root-causes-remain-unaddressed.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 2,
|
||||
"kept": 0,
|
||||
"fixed": 2,
|
||||
"rejected": 2,
|
||||
"fixes_applied": [
|
||||
"glp-1-adoption-produced-first-measurable-population-level-obesity-decline-demonstrating-pharmaceutical-intervention-can-shift-population-health-outcomes.md:set_created:2026-03-15",
|
||||
"glp-1-access-inequality-risks-creating-two-tier-metabolic-health-system-where-pharmacological-prevention-stratifies-by-wealth-while-root-causes-remain-unaddressed.md:set_created:2026-03-15"
|
||||
],
|
||||
"rejections": [
|
||||
"glp-1-adoption-produced-first-measurable-population-level-obesity-decline-demonstrating-pharmaceutical-intervention-can-shift-population-health-outcomes.md:missing_attribution_extractor",
|
||||
"glp-1-access-inequality-risks-creating-two-tier-metabolic-health-system-where-pharmacological-prevention-stratifies-by-wealth-while-root-causes-remain-unaddressed.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-15"
|
||||
}
|
||||
|
|
@ -7,10 +7,14 @@ date: 2025-00-00
|
|||
domain: internet-finance
|
||||
secondary_domains: [collective-intelligence, ai-alignment]
|
||||
format: paper
|
||||
status: unprocessed
|
||||
status: null-result
|
||||
priority: high
|
||||
tags: [futarchy, DeSci, DAOs, empirical-evidence, VitaDAO, simulation, governance-cadence]
|
||||
flagged_for_theseus: ["DeSci governance patterns relevant to AI alignment coordination mechanisms"]
|
||||
processed_by: rio
|
||||
processed_date: 2026-03-15
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
extraction_notes: "LLM returned 3 claims, 3 rejected by validator"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -43,3 +47,10 @@ Academic paper examining futarchy adoption in DeSci (Decentralized Science) DAOs
|
|||
PRIMARY CONNECTION: [[speculative markets aggregate information through incentive and selection effects not wisdom of crowds]]
|
||||
WHY ARCHIVED: Peer-reviewed evidence that futarchy converges with voting in low-information-asymmetry environments — defines the boundary condition where markets DON'T beat votes
|
||||
EXTRACTION HINT: Focus on the boundary condition claim — when does futarchy add value vs when does it converge with voting? The information asymmetry dimension is the key variable
|
||||
|
||||
|
||||
## Key Facts
|
||||
- VitaDAO retrospective simulation covered proposals up to April 2025
|
||||
- 13 DeSci DAOs analyzed: AthenaDAO, BiohackerDAO, CerebrumDAO, CryoDAO, GenomesDAO, HairDAO, HippocratDAO, MoonDAO, PsyDAO, VitaDAO, and others
|
||||
- Most DeSci DAOs operate below 1 proposal/month governance frequency
|
||||
- Paper published in Frontiers in Blockchain, peer-reviewed academic journal
|
||||
|
|
|
|||
|
|
@ -12,7 +12,7 @@ priority: medium
|
|||
tags: [nhs, universal-coverage, waiting-times, underfunding, international-comparison, uk-healthcare]
|
||||
processed_by: vida
|
||||
processed_date: 2026-03-15
|
||||
enrichments_applied: ["gatekeeping-systems-optimize-primary-care-at-the-expense-of-specialty-access-creating-structural-bottlenecks.md", "us-healthcare-ranks-last-among-peer-nations-despite-highest-spending-because-access-and-equity-failures-override-clinical-quality.md"]
|
||||
enrichments_applied: ["gatekeeping-systems-optimize-primary-care-at-the-expense-of-specialty-access-creating-structural-bottlenecks.md", "us-healthcare-ranks-last-among-peer-nations-despite-highest-spending-because-access-and-equity-failures-override-clinical-quality.md", "medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
|
|
@ -67,12 +67,13 @@ EXTRACTION HINT: The paradox of ranking 3rd overall while having worst specialty
|
|||
|
||||
|
||||
## Key Facts
|
||||
- NHS waiting list: 7.5 million patients as of 2024-2025
|
||||
- NHS 18-week standard achievement: 58.9% (target: 92%)
|
||||
- NHS diagnostic test delays: 22% waiting >6 weeks (standard: 1%)
|
||||
- NHS waiting list target: must halve to 3.4 million to reach 92% standard
|
||||
- NHS March 2026 target: 65% within 18 weeks (unlikely to be met)
|
||||
- NHS diagnostic test shortfall: 3.6 million tests
|
||||
- NHS respiratory medicine waiting list growth: 263% over past decade
|
||||
- NHS gynaecology waiting list growth: 223% over past decade
|
||||
- Commonwealth Fund Mirror Mirror 2024: NHS ranked 3rd overall
|
||||
- NHS has 7.5 million patients on waiting lists as of 2024-2025
|
||||
- Only 58.9% of NHS waiting patients seen within 18-week target (standard: 92%)
|
||||
- 22% of NHS patients wait over 6 weeks for diagnostic tests (standard: 1%)
|
||||
- NHS waiting list must be halved to 3.4 million to reach 92% standard
|
||||
- NHS target of 65% within 18 weeks by March 2026 unlikely to be met
|
||||
- NHS respiratory medicine waiting lists increased 263% over past decade
|
||||
- NHS gynaecology waiting lists increased 223% over past decade
|
||||
- NHS has shortfall of 3.6 million diagnostic tests
|
||||
- NHS ranks 3rd overall in Commonwealth Fund Mirror Mirror 2024
|
||||
- Trauma/orthopaedics and ENT have largest NHS waiting times
|
||||
|
|
|
|||
|
|
@ -6,9 +6,12 @@ url: "https://www.futard.io/proposal/CJW4iZPT14sVNzoc4Yibx1LbnY12sA75gZCP9HZk11U
|
|||
date: 2025-01-13
|
||||
domain: internet-finance
|
||||
format: data
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
tags: [futardio, metadao, futarchy, solana, governance]
|
||||
event_type: proposal
|
||||
processed_by: rio
|
||||
processed_date: 2026-03-15
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Proposal Details
|
||||
|
|
@ -53,3 +56,13 @@ If approved, this proposal would sanction the addition of a JTO Vault to the Tip
|
|||
- Autocrat version: 0.3
|
||||
- Completed: 2025-01-18
|
||||
- Ended: 2025-01-18
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Jito DAO proposal CJW4iZPT14sVNzoc4Yibx1LbnY12sA75gZCP9HZk11UA was proposal number 1 for the DAO
|
||||
- The proposal used Autocrat version 0.3
|
||||
- DAO account: B3PDBD7NCsJyxSdSDFEK38oNKZMBrgkg46TuqqkgAwPp
|
||||
- Proposer account: proPaC9tVZEsmgDtNhx15e7nSpoojtPD3H9h4GqSqB2
|
||||
- Proposal created 2025-01-13, completed and ended 2025-01-18
|
||||
- Discussion occurred on Discord at discord.gg/QtGpxC52Kw
|
||||
- JIP-10 forum discussion: https://forum.jito.network/t/jip-10-decision-market-on-whether-to-adopt-jto-in-the-tiprouter-ncn-protocol-development/463
|
||||
|
|
|
|||
|
|
@ -7,9 +7,13 @@ date: 2025-02-01
|
|||
domain: ai-alignment
|
||||
secondary_domains: [collective-intelligence]
|
||||
format: paper
|
||||
status: unprocessed
|
||||
status: null-result
|
||||
priority: high
|
||||
tags: [impossibility-result, agreement-complexity, reward-hacking, multi-objective, safety-critical-slices]
|
||||
processed_by: theseus
|
||||
processed_date: 2026-03-15
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
extraction_notes: "LLM returned 3 claims, 3 rejected by validator"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -48,3 +52,9 @@ Formalizes AI alignment as a multi-objective optimization problem where N agents
|
|||
PRIMARY CONNECTION: [[universal alignment is mathematically impossible because Arrows impossibility theorem applies to aggregating diverse human preferences into a single coherent objective]]
|
||||
WHY ARCHIVED: Third independent impossibility result from multi-objective optimization — convergent evidence from three mathematical traditions strengthens our core impossibility claim
|
||||
EXTRACTION HINT: The convergence of three impossibility traditions AND the "consensus-driven reduction" pathway are both extractable
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Paper presented as oral presentation at AAAI 2026 Special Track on AI Alignment
|
||||
- Formalizes AI alignment as multi-objective optimization problem with N agents and M objectives
|
||||
- Paper identifies 'No-Free-Lunch principle' for alignment: irreducible computational costs regardless of method sophistication
|
||||
|
|
|
|||
|
|
@ -6,9 +6,12 @@ url: "https://www.futard.io/proposal/DnDiyjAcmS3BNmNEJa2ydEbd6DgnddpkyVXJfngdRTz
|
|||
date: 2025-02-04
|
||||
domain: internet-finance
|
||||
format: data
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
tags: [futardio, metadao, futarchy, solana, governance]
|
||||
event_type: proposal
|
||||
processed_by: rio
|
||||
processed_date: 2026-03-15
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Proposal Details
|
||||
|
|
@ -53,3 +56,12 @@ If approved, this proposal would sanction the development and implementation of
|
|||
- Autocrat version: 0.3
|
||||
- Completed: 2025-02-07
|
||||
- Ended: 2025-02-07
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Marinade MIP.5 proposal account: DnDiyjAcmS3BNmNEJa2ydEbd6DgnddpkyVXJfngdRTzF
|
||||
- Marinade DAO account: 9RNQx6cnheD4tzvRCW5Mo1sTo72Vm6PbPj6SFC5aK4fy
|
||||
- Proposal used Autocrat version 0.3
|
||||
- Proposal completed and ended on 2025-02-07
|
||||
- Proposal discussion hosted on Discord: https://discord.gg/Bkc2EMEF6n
|
||||
- Forum discussion at: https://forum.marinade.finance/t/mip-5-sam-bid-routing-to-mnde-stakers/1700
|
||||
|
|
|
|||
|
|
@ -6,9 +6,12 @@ url: "https://www.futard.io/proposal/6TkkCy26HCqxWGt1QgfhFHc6ASikRjk74Gkk4Wfyd7w
|
|||
date: 2025-02-13
|
||||
domain: internet-finance
|
||||
format: data
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
tags: [futardio, metadao, futarchy, solana, governance]
|
||||
event_type: proposal
|
||||
processed_by: rio
|
||||
processed_date: 2026-03-15
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Proposal Details
|
||||
|
|
@ -94,3 +97,13 @@ The DWG will be led by Socrates, bringing 3+ years of crypto marketing expertise
|
|||
- Autocrat version: 0.3
|
||||
- Completed: 2025-02-16
|
||||
- Ended: 2025-02-16
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Drift Working Group proposal account: 6TkkCy26HCqxWGt1QgfhFHc6ASikRjk74Gkk4Wfyd7wR
|
||||
- Drift Working Group proposal number: 2 on futard.io
|
||||
- Drift Working Group budget: 50,000 DRIFT total (15,400 per month for 3 months, 3,800 for initiatives)
|
||||
- Drift Working Group team structure: 1 lead (5,000 DRIFT/month) + 4 members (2,600 DRIFT/month each)
|
||||
- Drift Working Group lead: Socrates, 3+ years crypto marketing experience
|
||||
- Drift Working Group fund management: 2/3 multisig (lead + two Drift team members)
|
||||
- Drift Working Group proposal completed: 2025-02-16
|
||||
|
|
|
|||
|
|
@ -6,7 +6,7 @@ url: "https://www.futard.io/proposal/EksJ2GhxbmhVAdDKP4kThHiuzKwjhq5HSb1kgFj6x2Q
|
|||
date: 2025-03-05
|
||||
domain: internet-finance
|
||||
format: data
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
tags: [futardio, metadao, futarchy, solana, governance]
|
||||
event_type: proposal
|
||||
processed_by: rio
|
||||
|
|
@ -14,6 +14,10 @@ processed_date: 2025-03-11
|
|||
enrichments_applied: ["MetaDAOs Autocrat program implements futarchy through conditional token markets where proposals create parallel pass and fail universes settled by time-weighted average price over a three-day window.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
extraction_notes: "This is raw proposal data from futard.io showing a passed proposal. No project name or proposal details provided beyond metadata. The data confirms operational use of Autocrat v0.3 but contains no arguable claims or novel insights—only verifiable transaction facts. Enriches existing claim about MetaDAO's Autocrat implementation with concrete production evidence."
|
||||
processed_by: rio
|
||||
processed_date: 2026-03-15
|
||||
enrichments_applied: ["MetaDAOs Autocrat program implements futarchy through conditional token markets where proposals create parallel pass and fail universes settled by time-weighted average price over a three-day window.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Proposal Details
|
||||
|
|
@ -41,3 +45,10 @@ extraction_notes: "This is raw proposal data from futard.io showing a passed pro
|
|||
- Autocrat version: 0.3
|
||||
- Status: Passed
|
||||
- Created, ended, and completed: 2025-03-05
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Proposal #1 on futard.io (account EksJ2GhxbmhVAdDKP4kThHiuzKwjhq5HSb1kgFj6x2Qu) passed on 2025-03-05
|
||||
- DAO account De8YzDKudqgeJXqq6i7q82AgxxrQ1JXXfMgouQuPyhY is using Autocrat version 0.3
|
||||
- Proposer account: 89VB5UmvopuCFmp5Mf8YPX28fGvvqn79afCgouQuPyhY
|
||||
- Proposal lifecycle (created, ended, completed) all occurred on same day: 2025-03-05
|
||||
|
|
|
|||
|
|
@ -6,9 +6,12 @@ url: "https://www.futard.io/proposal/HCHkdhiPh2q9LTyvUpfyfuybPHW7qg1T2vGtiJzGPrs
|
|||
date: 2025-03-05
|
||||
domain: internet-finance
|
||||
format: data
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
tags: [futardio, metadao, futarchy, solana, governance]
|
||||
event_type: proposal
|
||||
processed_by: rio
|
||||
processed_date: 2026-03-15
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Proposal Details
|
||||
|
|
@ -27,3 +30,11 @@ event_type: proposal
|
|||
- Autocrat version: 0.3
|
||||
- Completed: 2025-03-08
|
||||
- Ended: 2025-03-08
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Futard.io Proposal #3 (HCHkdhiPh2q9LTyvUpfyfuybPHW7qg1T2vGtiJzGPrsG) was created on 2025-03-05
|
||||
- Proposal #3 used Autocrat version 0.3
|
||||
- Proposal #3 completed and passed on 2025-03-08
|
||||
- Proposal #3 ran on DAO account 5n61x4BeVvvRMcYBMaorhu1MaZDViYw6HghE8gwLCvPR
|
||||
- Proposal #3 was submitted by proposer 89VB5UmvopuCFmp5Mf8YPX28fGvvqn79afCgouQuPyhY
|
||||
|
|
|
|||
|
|
@ -6,9 +6,12 @@ url: "https://www.futard.io/proposal/2dvNKyxKzVuUMcd89wzfuYjX2RKbJps2Srqu4mJ7LEg
|
|||
date: 2025-04-22
|
||||
domain: internet-finance
|
||||
format: data
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
tags: [futardio, metadao, futarchy, solana, governance]
|
||||
event_type: proposal
|
||||
processed_by: rio
|
||||
processed_date: 2026-03-15
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Proposal Details
|
||||
|
|
@ -48,3 +51,14 @@ This would be the test example for transferring the MetaDAO treasury of USDC to
|
|||
- Autocrat version: 0.3
|
||||
- Completed: 2025-04-22
|
||||
- Ended: 2025-04-22
|
||||
|
||||
|
||||
## Key Facts
|
||||
- Test DAO proposal 'Testing v0.3 Transfer' passed on 2025-04-22
|
||||
- Proposal aimed to transfer MetaDAO treasury USDC to v0.4 DAO
|
||||
- Proposal account: 2dvNKyxKzVuUMcd89wzfuYjX2RKbJps2Srqu4mJ7LEgC
|
||||
- Proposal number: 1
|
||||
- DAO account: GCSGFCRfCRQDbqtPLa6bV7DCJz26NkejR182or8PNqRw
|
||||
- Proposer: 8Cwx4yR2sFAC5Pdx2NgGHxCk1gJrtSTxJoyqVonqndhq
|
||||
- Autocrat version: 0.3
|
||||
- Proposal completed and ended: 2025-04-22
|
||||
|
|
|
|||
|
|
@ -7,9 +7,13 @@ date: 2025-06-01
|
|||
domain: health
|
||||
secondary_domains: [entertainment, internet-finance]
|
||||
format: paper
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: medium
|
||||
tags: [glp-1, obesity, societal-impact, equity, food-systems, population-health, sustainability]
|
||||
processed_by: vida
|
||||
processed_date: 2026-03-15
|
||||
enrichments_applied: ["GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md", "Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated.md", "the epidemiological transition marks the shift from material scarcity to social disadvantage as the primary driver of health outcomes in developed nations.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -52,3 +56,11 @@ EXTRACTION HINT: Focus on both the population-level effect AND the equity concer
|
|||
|
||||
flagged_for_clay: ["GLP-1 adoption is reshaping cultural narratives around obesity, body image, and pharmaceutical solutions to behavioral problems — connects to health narrative infrastructure"]
|
||||
flagged_for_rio: ["GLP-1 equity gap creates investment opportunity in access-focused models that serve underserved populations — potential Living Capital thesis"]
|
||||
|
||||
|
||||
## Key Facts
|
||||
- October 2025 Gallup poll: 12.4% of US adults taking GLP-1 for weight loss (30M+ people)
|
||||
- US obesity prevalence: 39.9% (2022) → 37.0% (2025), representing 7.6M fewer obese Americans
|
||||
- WHO issued conditional recommendations for GLP-1s in December 2025
|
||||
- Obesity costs US $400B+ annually
|
||||
- WHO three-pillar approach: healthier environments (population policy), protect high-risk individuals, person-centered care
|
||||
|
|
|
|||
Loading…
Reference in a new issue